img

Global TNF Alpha Inhibitor Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global TNF Alpha Inhibitor Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global TNF Alpha Inhibitor Market Segment Research Report 2022》, which aims to sort out the development status and trends of the TNF Alpha Inhibitor industry at home and abroad, estimate the overall market scale of the TNF Alpha Inhibitor industry and the market share of major countries, TNF Alpha Inhibitor industry, and study and judge the downstream market demand of TNF Alpha Inhibitor through systematic research, Analyze the competition pattern of TNF Alpha Inhibitor, so as to help solve the pain points of various stakeholders in TNF Alpha Inhibitor industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of TNF Alpha Inhibitor Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in TNF Alpha Inhibitor Market?
AbbVie Inc.
Amgen Inc.
Johnson and Johnson
UCB SA
Novartis International AG
Pfizer
Merck and co.
Janssen Biotech
Ablynx
Momenta
Major Type of TNF Alpha Inhibitor Covered in XYZResearch report
Remicade (Infliximab)
Enbrel (Etanercept)
Humira (Adalimumab)
Cimzia (Certolizumab Pegol)
Simponi (Golimumab)
Application Segments Covered in XYZResearch Market
Inflammatory Bowel Disease
Psoriatic Arthritis
Ulcerative Colitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global TNF Alpha Inhibitor Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global TNF Alpha Inhibitor Market by Value
2.2.1 Global TNF Alpha Inhibitor Revenue by Type
2.2.2 Global TNF Alpha Inhibitor Market by Value (%)
2.3 Global TNF Alpha Inhibitor Market by Production
2.3.1 Global TNF Alpha Inhibitor Production by Type
2.3.2 Global TNF Alpha Inhibitor Market by Production (%)

3. The Major Driver of TNF Alpha Inhibitor Industry
3.1 Historical & Forecast Global TNF Alpha Inhibitor Demand
3.2 Largest Application for TNF Alpha Inhibitor (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional TNF Alpha Inhibitor Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of TNF Alpha Inhibitor Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US TNF Alpha Inhibitor Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe TNF Alpha Inhibitor Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China TNF Alpha Inhibitor Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan TNF Alpha Inhibitor Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India TNF Alpha Inhibitor Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea TNF Alpha Inhibitor Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia TNF Alpha Inhibitor Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global TNF Alpha Inhibitor Average Price Trend
12.1 Market Price for Each Type of TNF Alpha Inhibitor in US (2018-2022)
12.2 Market Price for Each Type of TNF Alpha Inhibitor in Europe (2018-2022)
12.3 Market Price for Each Type of TNF Alpha Inhibitor in China (2018-2022)
12.4 Market Price for Each Type of TNF Alpha Inhibitor in Japan (2018-2022)
12.5 Market Price for Each Type of TNF Alpha Inhibitor in India (2018-2022)
12.6 Market Price for Each Type of TNF Alpha Inhibitor in Korea (2018-2022)
12.7 Market Price for Each Type of TNF Alpha Inhibitor in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 TNF Alpha Inhibitor Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of TNF Alpha Inhibitor

14. TNF Alpha Inhibitor Competitive Landscape
14.1 AbbVie Inc.
14.1.1 AbbVie Inc. Company Profiles
14.1.2 AbbVie Inc. Product Introduction
14.1.3 AbbVie Inc. TNF Alpha Inhibitor Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Amgen Inc.
14.2.1 Amgen Inc. Company Profiles
14.2.2 Amgen Inc. Product Introduction
14.2.3 Amgen Inc. TNF Alpha Inhibitor Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Johnson and Johnson
14.3.1 Johnson and Johnson Company Profiles
14.3.2 Johnson and Johnson Product Introduction
14.3.3 Johnson and Johnson TNF Alpha Inhibitor Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 UCB SA
14.4.1 UCB SA Company Profiles
14.4.2 UCB SA Product Introduction
14.4.3 UCB SA TNF Alpha Inhibitor Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Novartis International AG
14.5.1 Novartis International AG Company Profiles
14.5.2 Novartis International AG Product Introduction
14.5.3 Novartis International AG TNF Alpha Inhibitor Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Pfizer
14.6.1 Pfizer Company Profiles
14.6.2 Pfizer Product Introduction
14.6.3 Pfizer TNF Alpha Inhibitor Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Merck and co.
14.7.1 Merck and co. Company Profiles
14.7.2 Merck and co. Product Introduction
14.7.3 Merck and co. TNF Alpha Inhibitor Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Janssen Biotech
14.8.1 Janssen Biotech Company Profiles
14.8.2 Janssen Biotech Product Introduction
14.8.3 Janssen Biotech TNF Alpha Inhibitor Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Ablynx
14.9.1 Ablynx Company Profiles
14.9.2 Ablynx Product Introduction
14.9.3 Ablynx TNF Alpha Inhibitor Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Momenta
14.10.1 Momenta Company Profiles
14.10.2 Momenta Product Introduction
14.10.3 Momenta TNF Alpha Inhibitor Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of TNF Alpha Inhibitor Industry (Volume)
Figure 2. TNF Alpha Inhibitor Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by TNF Alpha Inhibitor Revenue in 2022
Figure 5. US TNF Alpha Inhibitor Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe TNF Alpha Inhibitor Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China TNF Alpha Inhibitor Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan TNF Alpha Inhibitor Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India TNF Alpha Inhibitor Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea TNF Alpha Inhibitor Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia TNF Alpha Inhibitor Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. TNF Alpha Inhibitor Revenue, by Type (Million USD) (2018-2028)
Table 4. TNF Alpha Inhibitor Production, by Type (K Unit) (2018-2028)
Table 5. TNF Alpha Inhibitor Demand (K Unit) by Application (2018-2028)
Table 6. TNF Alpha Inhibitor Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top TNF Alpha Inhibitor Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US TNF Alpha Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe TNF Alpha Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China TNF Alpha Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan TNF Alpha Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India TNF Alpha Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea TNF Alpha Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia TNF Alpha Inhibitor Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of TNF Alpha Inhibitor in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of TNF Alpha Inhibitor in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of TNF Alpha Inhibitor in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of TNF Alpha Inhibitor in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of TNF Alpha Inhibitor in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of TNF Alpha Inhibitor in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of TNF Alpha Inhibitor in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. AbbVie Inc. Profiles
Table 61. AbbVie Inc. TNF Alpha Inhibitor Product Introduction
Table 62. AbbVie Inc. TNF Alpha Inhibitor Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. AbbVie Inc. Strategic initiatives
Table 64. Amgen Inc. Profiles
Table 65. Amgen Inc. TNF Alpha Inhibitor Product Introduction
Table 66. Amgen Inc. TNF Alpha Inhibitor Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Amgen Inc. Strategic initiatives
Table 68. Johnson and Johnson Profiles
Table 69. Johnson and Johnson TNF Alpha Inhibitor Product Introduction
Table 70. Johnson and Johnson TNF Alpha Inhibitor Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Johnson and Johnson Strategic initiatives
Table 72. UCB SA Profiles
Table 73. UCB SA TNF Alpha Inhibitor Product Introduction
Table 74. UCB SA TNF Alpha Inhibitor Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. UCB SA Strategic initiatives
Table 76. Novartis International AG Profiles
Table 77. Novartis International AG TNF Alpha Inhibitor Product Introduction
Table 78. Novartis International AG TNF Alpha Inhibitor Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Novartis International AG Strategic initiatives
Table 80. Pfizer Profiles
Table 81. Pfizer TNF Alpha Inhibitor Product Introduction
Table 82. Pfizer TNF Alpha Inhibitor Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Pfizer Strategic initiatives
Table 84. Merck and co. Profiles
Table 85. Merck and co. TNF Alpha Inhibitor Product Introduction
Table 86. Merck and co. TNF Alpha Inhibitor Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Merck and co. Strategic initiatives
Table 88. Janssen Biotech Profiles
Table 89. Janssen Biotech TNF Alpha Inhibitor Product Introduction
Table 90. Janssen Biotech TNF Alpha Inhibitor Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Janssen Biotech Strategic initiatives
Table 92. Ablynx Profiles
Table 93. Ablynx TNF Alpha Inhibitor Product Introduction
Table 94. Ablynx TNF Alpha Inhibitor Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Ablynx Strategic initiatives
Table 97. Momenta Profiles
Table 98. Momenta TNF Alpha Inhibitor Product Introduction
Table 99. Momenta TNF Alpha Inhibitor Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Momenta Strategic initiatives